BWLSA
GH icon

Blue Water Life Science Advisors’s Guardant Health GH Stock Holding History

Blue Water Life Science Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Sell
114,747
-127,500
-53% -$13.9M 10.84% 5
2026
Q1 		$22.4M Sell
242,247
-112,800
-32% -$11.3M 17.94% 2
2025
Q4 		$36.3M Sell
355,047
-50,600
-12% -$4.53M 22.76% 1
2025
Q3 		$25.3M Sell
405,647
-33,400
-8% -$1.82M 23.12% 2
2025
Q2 		$22.8M Sell
439,047
-255,000
-37% -$11.4M 18.09% 3
2025
Q1 		$29.6M Hold
694,047
– – 29.3% 1
2024
Q4 		$21.2M Buy
694,047
+243,000
+54% +$6.84M 18.77% 2
2024
Q3 		$10.3M Sell
451,047
-120,000
-21% -$3.4M 9.1% 6
2024
Q2 		$16.5M Hold
571,047
– – 16.04% 2
2024
Q1 		$11.8M Hold
571,047
– – 11.08% 3
2023
Q4 		$15.4M Sell
571,047
-105,000
-16% -$2.75M 13.53% 3
2023
Q3 		$20M Hold
676,047
– – 18.92% 3
2023
Q2 		$24.2M Buy
676,047
+185,602
+38% +$5.33M 16.34% 3
2023
Q1 		$11.5M Sell
490,445
-378,000
-44% -$10.8M 7.6% 5
2022
Q4 		$23.6M Sell
868,445
-110,000
-11% -$5.03M 15.87% 2
2022
Q3 		$52.7M Buy
978,445
+144,300
+17% +$7.41M 21.26% 1
2022
Q2 		$33.6M Buy
834,145
+172,700
+26% +$8.56M 18.27% 1
2022
Q1 		$43.8M Buy
661,445
+270,500
+69% +$18.5M 20.79% 2
2021
Q4 		$39.1M Buy
390,945
+264,121
+208% +$27.3M 11.96% 3
2021
Q3 		$15.9M Sell
126,824
-103,771
-45% -$12.3M 5.16% 8
2021
Q2 		$28.6M Buy
230,595
+45,265
+24% +$6.09M 10.78% 6
2021
Q1 		$28.3M Buy
185,330
+44,430
+32% +$6.71M 13.82% 4
2020
Q4 		$18.2M Buy
+140,900
New +$16.2M 10.66% 3

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Blue Water Life Science Advisors's GH Position: Q2 2026 in Review

Blue Water Life Science Advisors reduced its Guardant Health (GH) stake by 53% in Q2 2026, selling an estimated $13.9M and leaving 114,747 shares worth $17.2M. The position accounts for 10.84% of the portfolio, ranked #5.

Blue Water Life Science Advisors first reported a position in GH in Q4 2020 and has held it in 23 quarters since. The position peaked at $52.7M in Q3 2022. 594 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Blue Water Life Science Advisors held 114,747 shares of Guardant Health worth $17.2M as of Q2 2026.
  • Blue Water Life Science Advisors sold 127,500 Guardant Health shares in Q2 2026, an estimated $13.9M.
  • Guardant Health made up 10.84% of Blue Water Life Science Advisors's portfolio in Q2 2026, its #5 holding.
  • Blue Water Life Science Advisors first reported a position in Guardant Health in Q4 2020 and has held it in 23 quarters since.
  • Blue Water Life Science Advisors's Guardant Health position peaked at $52.7M in Q3 2022.
  • 594 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.